The renowned medical device company has a market capitalization of $9.18 billion. IDEXX has an earnings yield of 2.49%, which ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective June 1, 2025. Andrew Emerson, ...

Pet healthcare firm IDEXX Laboratories, Inc. (IDXX) announced Thursday that Brian McKeon has decided to retire from IDEXX effective ...

Idexx Laboratories (IDXX) announced that Brian McKeon has decided to retire from Idexx effective June 1, 2025. Andrew Emerson, currently senior VP, corporate and companion animal group finance, will ...

IDEXX's Q3 results showed a 2.1% decline in same-store clinical visits and missed market expectations. Read why I reiterate a ...

We note that IDEXX Laboratories, Inc. (NASDAQ:IDXX) does have debt on its balance sheet. But the real question is whether this debt is making the company risky. Debt and other liabilities become risky ...

Under Mr. McKeon's leadership, the CAG business now generates more than 90% of IDEXX’s total revenue, indicating significant growth for the company. Additionally, Mr. Emerson has overseen corporate ...

Meeder Asset Management Inc. increased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 616.0% during the ...

Good morning, and welcome to the IDEXX Laboratories Third Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...